Skip to Main Content
Pharmacy Technician's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes

Diabetes

  • Diabetes (421)
    • Blood Glucose Meters (3)
    • Complications (100)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (54)
    • Drug-Induced Hypo/Hyperglycemia (93)
    • Monitoring (75)
    • Natural Medicines/Supplements (8)
    • Prevention (26)
    • Treatment (185)
  • Endocrinology (9)
  • Hyperglycemia (22)
  • Hypoglycemia (21)
  • Other (15)
  • Prediabetes (2)
  • Resources (125)
  • Thyroid Disorders (41)
316 - 330 of 421 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Avandia (Rosiglitazone) and the Risk of Myocardial Infarction July 2007
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) July 2007
Chart: Avandia (rosiglitazone) and the risk of myocardial infarction June 2007
Other: New Insulin Premix Formulation: NovoMix 30 April 2007
Other: Glitazones and Increased Fracture Risk April 2007
Other: Choosing Initial Monotherapy for Type 2 Diabetes: the ADOPT study January 2007
Other: Hypurin Regular and Hypurin NPH (Pork) Insulins November 2006
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2006
Other: Preventing the Development of Diabetes--The DREAM Trial October 2006
Other: The Use of Glitazones in Patients with Congestive Heart Failure September 2006
Commentary: Diabetes Peripheral Neuropathic Pain Treatment August 2006
Guideline: Consensus Guidelines: Treatment Planning and Options (2006) August 2006
Other: Inpatient Management of Hyperglycemia April 2006
Other: Insulin For Oral Inhalation (Exubera) March 2006
Other: Sulfonylureas and the Risk of Mortality March 2006
  • « Prev
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved